Schedule 13G ownership disclosure
CNS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 18978H201
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,667
- Percent of class
- 0.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-23-001042
- Form type
- SC 13G
- Filer
- CNS Pharmaceuticals, Inc.
- CIK
- CIK 1729427
- Filed
- Aug 01, 2023
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership